Skip to content
CNS Clinical Research

Utah

CNS clinical trials in Utah

52 CNS studies are recruiting participants at sites in 10 cities across Utah as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Utah city with a recruiting study

By research area: Depression (21), Migraine (10), Parkinson's Disease (7), Epilepsy (5), Multiple Sclerosis (4), ADHD (3), Bipolar Disorder (1), Schizophrenia (1).

Salt Lake City (32), Clinton (7), Bountiful (6), Draper (6), Orem (5), Ogden (4), Provo (4), Murray (2), Riverton (2), Logan (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Utah

Basic details from each study's public record (the 12 most recently updated of 52). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Recruiting in
    Clinton · Salt Lake City
    Registry record
    NCT07226661 · updated
  2. RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

    • Phase 2
    • Ages 18 to 80
    • All sexes
    Sponsor
    Reunion Neuroscience Inc
    Recruiting in
    Draper
    Registry record
    NCT07002034 · updated
  3. A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

    • Phase 3
    • Ages 18 to 74
    • All sexes
    Sponsor
    Definium Therapeutics US, Inc.
    Recruiting in
    Draper · Orem
    Registry record
    NCT07592689 · updated
  4. Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Utah
    Recruiting in
    Salt Lake City
    Registry record
    NCT06767566 · updated
  5. ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    ACADIA Pharmaceuticals Inc.
    Recruiting in
    Salt Lake City
    Registry record
    NCT07284667 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Utah on ClinicalTrials.gov.

ADHD: recently updated in Utah

  1. The Myelin Disorders Biorepository Project

    • Observational
    • All ages
    • All sexes
    Sponsor
    Children's Hospital of Philadelphia
    Recruiting in
    Salt Lake City
    Registry record
    NCT03047369 · updated
  2. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)

    • Phase 3
    • Ages 6 to 11
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Recruiting in
    Provo
    Registry record
    NCT07717879 · updated
  3. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Recruiting in
    Provo
    Registry record
    NCT07717892 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Utah on ClinicalTrials.gov.

Parkinson's disease: recently updated in Utah

  1. A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Salt Lake City
    Registry record
    NCT06841354 · updated
  2. A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Murray
    Registry record
    NCT06966700 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Utah on ClinicalTrials.gov.

Migraine: recently updated in Utah

  1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    • Phase 4
    • Ages 18 to 70
    • All sexes
    Sponsor
    Mayo Clinic
    Recruiting in
    Ogden
    Registry record
    NCT06972056 · updated
  2. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Salt Lake City
    Registry record
    NCT07816367 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Utah on ClinicalTrials.gov.

Ask about studies in Utah

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call